• Inhibition of cardiac potassium currents by oxidation-activated protein kinase A contributes to early afterdepolarizations in the heart 

  Trum, M; Islam, MMT; Lebek, S; Baier, M; Hegner, P; Eaton, P; Maier, LS; Wagner, S (2020-12)

• Oxidation of Protein Kinase A Regulatory Subunit PKARI alpha Protects Against Myocardial Ischemia-Reperfusion Injury by Inhibiting Lysosomal-Triggered Calcium Release 

  Simon, JN; Vrellaku, B; Monterisi, S; Chu, SM; Rawlings, N; Lomas, O; Marchal, GA; Waithe, D; Syeda, F; Gajendragadkar, PR (2021-02-02)

• Enhanced Heart Failure in Redox-Dead Cys17Ser PKARI alpha Knock-In Mice 

  Islam, MMT; Tarnowski, D; Zhang, M; Trum, M; Lebek, S; Mustroph, J; Daniel, H; Moellencamp, J; Pabel, S; Sossalla, S (2021-10-05)

• Nitroxyl Donor CXL-1020 Lowers Blood Pressure by Targeting C195 in Cyclic Guanosine-3',5'-Monophosphate-Dependent Protein Kinase I 

  Kamynina, A; Guttzeit, S; Eaton, P; Cuello, F (2022-05)

• Heart failure-emerging roles for the mitochondrial pyruvate carrier 

  Fernandez-Caggiano, M; Eaton, P (2021-04)

• Prescribing direct-acting oral anticoagulants - Mind the evidence gap 

  Adeyeye, E; Maniero, C; Magavern, EF; Ferner, RE; McGettigan, P (2022-07-13)

• Redox Regulation of Soluble Epoxide Hydrolase-Implications for Cardiovascular Health and Disease 

  Charles, R; Eaton, P (2022-06)

• Hydrogen peroxide signaling via its transformation to a stereospecific alkyl hydroperoxide that escapes reductive inactivation 

  Queiroz, RF; Stanley, CP; Wolhuter, K; Kong, SMY; Rajivan, R; McKinnon, N; Nguyen, GTH; Roveri, A; Guttzeit, S; Eaton, P (2021-11-16)

• Real-world use of the Breathing Pattern Assessment Tool in assessment of breathlessness post-COVID-19 

  Hylton, H; Long, A; Francis, C; Taylor, RR; Ricketts, WM; Singh, R; Pfeffer, PE (2022-07)

• Left atrial structure and function are associated with cardiovascular outcomes independent of left ventricular measures: a UK Biobank CMR study (Dec, 10.1093/ehjci/jeab266, 2021) 

  Raisi-Estabragh, Z; McCracken, C; Condurache, D-G; Aung, N; Vargas, JD; Naderi, H; Munroe, PB; Neubauer, S; Harvey, NC; Petersen, SE (2022-06-15)

• 100,000 Genomes Pilot on Rare-Disease Diagnosis in Health Care - Preliminary Report 

  Smedley, D; Smith, KR; Martin, A; Thomas, EA; McDonagh, EM; Cipriani, V; Ellingford, JM; Arno, G; Tucci, A; Vandrovcova, J (2021-11-11)

• Frequency, Penetrance, and Variable Expressivity of Dilated Cardiomyopathy-Associated Putative Pathogenic Gene Variants in UK Biobank Participants 

  Shah, RA; Asatryan, B; Dabbagh, GS; Aung, N; Khanji, MY; Lopes, LR; van Duijvenboden, S; Holmes, A; Muser, D; Landstrom, AP (2022-07-12)

• Discovery of rare variants associated with blood pressure regulation through meta-analysis of 1.3 million individuals (vol 52, pg 1314, 2020) 

  Surendran, P; Feofanova, EV; Lahrouchi, N; Ntalla, I; Karthikeyan, S; Cook, J; Chen, L; Mifsud, B; Yao, C; Kraja, AT (2021-05)

• Enhanced NF-kappa B signaling in type-2 dendritic cells at baseline predicts non-response to adalimumab in psoriasis 

  Andres-Ejarque, R; Ale, HB; Grys, K; Tosi, I; Solanky, S; Ainali, C; Catak, Z; Sreeneebus, H; Saklatvala, J; Dand, N (2021-08-06)

• IL-23-induced STAT3 translocation in MAIT cells at baseline is a candidate biomarker of response for biologics targeting the IL-23/IL-17 axis 

  Solanky, S; Ejarque, RA; Khan, S; Tosi, I; Dawe, H; Dand, N; Mahil, S; Barnes, MR; Griffiths, CEM; Reynolds, NJ (2022-06)

• Meeting Report: Psoriasis Stratification to Optimize Relevant Therapy Showcase 

  Yiu, ZZN; Barker, JNWN; Barnes, MR; Di Meglio, P; Emsley, R; Reynolds, NJ; Smith, CH; Warren, RB; Griffiths, CEM; Consortium, PSORT (2021-08)

• Interleukin-23-induced STAT3 translocation in circulating mucosal-associated invariant T cells is a potential biomarker of clinical response to ustekinumab in psoriasis 

  Solanky, S; Ejarque, RA; Tosi, I; Dawe, H; Dand, N; Mahil, S; Barnes, MR; Griffiths, CEM; Reynolds, NJ; Smith, CH (2022-01)

• Relative frequency of monocyte subsets at baseline in psoriasis is associated with clinical outcome to secukinumab therapy 

  Hardman-Smart, JA; Ejarque, RA; Solanky, S; Tosi, I; Grys, K; Nichols, E; Villanova, F; Barnes, MR; Barker, J; Griffiths, CEM (2022-01)

• Phospholemman Phosphorylation Regulates Vascular Tone, Blood Pressure, and Hypertension in Mice and Humans 

  Boguslavskyi, A; Tokar, S; Prysyazhna, O; Rudyk, O; Sanchez-Tatay, D; Lemmey, HAL; Dora, KA; Garland, CJ; Warren, HR; Doney, A (2021-03-16)

• Author Correction: Enhanced NF-κB signaling in type-2 dendritic cells at baseline predicts non-response to adalimumab in psoriasis. 

  Andres-Ejarque, R; Ale, HB; Grys, K; Tosi, I; Solanky, S; Ainali, C; Catak, Z; Sreeneebus, H; Saklatvala, J; Dand, N (2021-12-16)

View more